Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an AI helper match a Doctor's kidney transplant Check-Up?

NCT ID NCT07842289

Knowledge-focused Sponsor: UPECLIN HC FM Botucatu Unesp Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 25, 2026 · Last updated Sep 25, 2026

Summary

Kidney transplant recipients need lifelong check-ups to keep their new kidney working, and clinics are getting busier. This trial tests whether a follow-up visit led by a health professional using an AI assistant is as good as a usual doctor visit. Researchers will randomly assign 140 adults with a working transplant to either an AI-assisted visit or a standard visit, then compare visit quality, patient satisfaction, time spent, and safety. The AI cannot order tests, change medicines, or make diagnoses on its own; a clinician reviews and approves everything.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
An AI assistant that supports clinicians during kidney transplant follow-up visits
What this could lead to
If it works, AI support could help clinics run consistent, thorough follow-up visits and free up clinician time for patients who need it most.
What could go wrong
This is a single-visit study of 140 people, so it cannot show long-term effects on transplant health. AI suggestions might miss important details or slow visits down, and results may not apply to other clinics or languages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2027

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older * Have a working kidney transplant * Received the kidney transplant at least 6 months ago * Able to take part in a routine follow-up visit on their own * Able to understand the study and give informed consent Exclusion Criteria: * Have a sudden or serious illness that needs urgent care * Have a thinking or sensory problem that means they need another person's help during the visit * Cannot communicate in Portuguese, the language used in the study * Are taking part in another study that would conflict with this one

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney transplant are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kidney transplant Transplant recipients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UPECLIN

    Botucatu, São Paulo, 18618-686, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.